Consonance Capital Partners, a leading healthcare-focused private equity fund, announced today that it signed a definitive agreement to sell Enclara Healthcare (“Enclara”), along with management, to Humana Inc. (NYSE: HUM or “Humana”). Certain assets are excluded from the transaction and terms have not been disclosed. Established over 20 years ago, Enclara is a leading pharmacy solutions provider focused on simplifying care delivery in complex care populations to improve patient experience, quality and cost.
Benjamin Edmands, Co-Founder and Managing Partner of Consonance Capital Partners, said, “It has been a pleasure to partner with Andy Horowitz, Stephen Phenneger, and the entire Enclara management team over the past half-decade. The team has done an outstanding job growing the company organically and through acquisition to create a market leading and technology driven pharmacy management business that can support the needs of both national and local hospice customers, palliative care nurses, patients, and their caregivers. We are excited to have Humana as a steward going forward for this business and the critical role that it plays within the hospice benefit and in serving other home-based chronic care patients. We wish the Enclara team success with their new partners.”
Andy Horowitz, CEO of Enclara added, “We greatly enjoyed working with the Consonance team. They have been a critical partner throughout Enclara’s evolution over the past five years from a small hospice-focused pharmacy into a national full-service specialized pharmacy management platform. We look forward to the next chapter for Enclara under Humana’s ownership.”
Since making the investment in Enclara in 2014, Consonance has worked side-by-side with the management team to support the Company’s transformative growth. During this time, Enclara completed the acquisition of ExcelleRx, PBM Holdings, and Avanti Health Care Services, enhanced service offerings, made significant investments into E3™, a proprietary medication ordering and management technology platform, and leveraged core competencies to expand into the chronic care pharmacy space.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Consonance Capital Partners and Enclara were advised by Evercore Inc. with Latham & Watkins LLP serving as counsel. Humana was advised by Centerview Partners LLC with Crowell & Moring LLP serving as counsel.
Source: BioSpace